Serum Institute of India leads cross-sector Indian investments into UK

The Pune-based vaccine manufacturer is among a list of nearly 20 Indian companies across sectors such as healthcare, biotech and software services to announce significant investment plans in the UK .It was also revealed that SII has started phase one trials in the UK of a nasal vaccine